Owsianka, A. M., Tarr, A. W., Keck, Z. Y., Li, T. K., Witteveldt, J., Adair, R., Foung, S. K., Ball, J. K. & Patel, A. H. (2008). Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein. J Gen Virol 89, 653–659. Pessoa, M. G., Terrault, N. A., Detmer, J., Kolberg, J., Colllins, M., Hassoba, H. M. & Wright, T. L. (1998). Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic. Hepatology 27, 877–880. Pilot-Matias, T. J., Carrick, R. J., Coleman, P. F., Leary, T. P., Surowy, T. K., Simons, J. N., Muerhoff, A. S., Buijk, S. L., Chalmers, M. L. & other authors (1996a). Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker. Virology 225, 282–292. Pilot-Matias, T. J., Muerhoff, A. S., Simons, J. N., Leary, T. P., Buijk, S. L., Chalmers, M. L., Erker, J. C., Dawson, G. J., Desai, S. M. & Mushawar, I. K. (1996b). Identification of antigenic regions in the GB hepatitis viruses GBV-A, GBV-B, and GBV-C. J Med Virol 48, 329–338. Polgreen, P. M., Xiang, J., Chang, Q. & Stapleton, J. T. (2003). GB virus type C/hepatitis G virus: a nonpathogenic flavivirus associated with prolonged survival in HIV-infected individuals. Microbes Infect 5, 1255–1261. Prince, A. M., Brotman, B., Grady, G. F., Kuhns, W. J., Hazzi, C., Levine, R. W. & Milan, S. J. (1974). Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. Lancet 2, 241–246. Radkowski, M., Wang, L. F., Cianciara, J., Rakela, J. & Laskus, T. (1999). Analysis of hepatitis G virus/GB virus C quasispecies and replication sites in human subjects. Biochem Biophys Res Commun 258, 296–299. Radkowski, M., Kubicka, J., Kisiel, E., Cianciara, J., Nowicki, M., Rakela, J. & Laskus, T. (2000). Detection of active hepatits C virus and hepatits G virus/GB virus C replication in bone marrow in human subjects. Blood 95, 3986–3989. Ren, H., Zhu, F. L., Cao, M. M., Wen, X. Y., Zhao, P. & Qi, Z. T. (2005). Hepatitis G virus genomic RNA is pathogenic to Macaca mulatta. World J Gastroenterol 11, 970–975. Robertson, B. H. (2001). Viral hepatitis and primates: historical and molecular analysis of human and nonhuman primate hepatitis A, B, and the GB-related viruses. J Viral Hepat 8, 233–242. Sakai, A., Claire, M. S., Faulk, K., Govindarajan, S., Emerson, S. U., Purcell, R. H. & Bukh, J. (2003). The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences. Proc Natl Acad Sci U S A 100, 11646– 11651. Sathar, M. A., Soni, P. N., Pegoraro, R., Simmonds, P., Smith, D. B., Dhillon, A. P. & Dusheiko, G. (1999). A new variant of GB virus C/ hepatitis G virus (GBV-HGV) from South Africa. Virus Res 64, 151– 160. Sbardellati, A., Scarselli, E., Verschoor, E., De Tomassi, A., Lazzaro, D. & Traboni, C. (2001). Generation of infectious and transmissible virions from a GB virus B full-length consensus clone in tamarins. J Gen Virol 82, 2437–2448. Scallan, M. F., Clutterbuck, D., Jarvis, L. M., Scott, G. R. & Simmonds, P. (1998). Sexual transmission of GB virus C/hepatitis G virus. J Med Virol 55, 203–208. Schaluder, G. G., Dawson, G. J., Simons, J. N., Pilot-Matias, T. J., Gutierrez, R. A., Heynen, C. A., Knigge, M. F., Kurpiewski, G. S., Buijk, S. L. & Leary, T. P. (1995). Molecular and serologic analysis in the transmission of the GB hepatitis agents. J Med Virol 46, 81–90. Schlauder, G. G., Pilot-Matias, T. J., Gabriel, G. S., Simons, J. N., Muerhoff, A. S., Dawson, G. J. & Mushawar, I. K. (1995). Origin of GB-hepatitis viruses. Lancet 346, 447–448. http://vir.sgmjournals.org The GB viruses Schwarze-Zander, C., Blackard, J. T., Zheng, H., Addo, M. M., Lin, W., Robbins, G. K., Sherman, K. E., Zdunek, D., Hess, G. & other authors (2006). GB virus C (GBV-C) infection in hepatitis C virus (HCV)/ HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. J Infect Dis 194, 410–419. Shimizu, Y. K., Weiner, A. J., Rosenblatt, J., Wong, D. C., Shapiro, M., Popkin, T., Houghton, M., Alter, H. J. & Purcell, R. H. (1990). Early events in hepatitis C virus infection of chimpanzees. Proc Natl Acad Sci U S A 87, 6441–6444. Simons, J. N., Leary, T. P., Dawson, G. J., Pilot-Matias, T. J., Muerhoff, A. S., Schlauder, G. G., Desai, S. M. & Mushahwar, I. K. (1995a). Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1, 564–569. Simons, J. N., Pilot-Matias, T. J., Leary, T. P., Dawson, G. J., Desai, G. J., Desai, S. M., Schlauder, G. G., Muerhoff, A. S., Erker, J. C. & other authors (1995b). Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci U S A 92, 3401– 3405. Simons, J. N., Desai, S. M., Schultz, D. E., Lemon, S. M. & Mushahwar, I. K. (1996). Translation initiation in GB viruses A and C: evidence for internal ribosome entry and implications for genomic organization. J Virol 70, 6126–6135. Simons, J. N., Desai, S. M. & Mushahwar, I. K. (2000). The GB viruses. Curr Top Microbiol Immunol 242, 341–375. Smith, D. B., Simmonds, P., Frost, S., Haydon, D., Cuceanu, N., Prescott, L., Kamenka, C., Millband, D., Sathar, M. A. & Simmonds, P. (2000). Phylogenetic analysis of GBV-C/hepatitis G virus. J Gen Virol 81, 769–780. Stapleton, J. T. (2003). GB virus type C/hepatitis G virus. Semin Liver Dis 23, 137–148. Tabor, E., Seeff, L. B. & Gerety, R. J. (1979). Lack of susceptibility of marmosets to human non-A, non-B hepatitis. J Infect Dis 140, 794– 797. Tabor, E., Peterson, D. A., April, M., Seeff, L. B. & Gerety, R. J. (1980). Transmission of human non-A, non-B hepatitis to chimpanzees following failure to transmit GB agent hepatitis. J Med Virol 5, 103– 108. Tacke, M., Schmolke, S., Schlueter, V., Sauleda, S., Esteban, J. I., Tanaka, E., Kiyosawa, K., Alter, H. J., Schmitt, U. & other authors (1997). Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology 26, 1626–1633. Takaki, A., Wiese, M., Maertens, G., Depla, E., Seifert, U., Liebetrau, A., Miller, J. L., Manns, M. P. & Rehermann, B. (2000). Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 6, 578– 582. Takikawa, S., Engle, R. E., Emerson, S. U., Purcell, R. H., St Claire, M. & Bukh, J. (2006). Functional analyses of GB virus B p13 protein: development of a recombinant GB virus B hepatitis virus with a p7 protein. Proc Natl Acad Sci U S A 103, 3345–3350. Tan, D., Matsumoto, A., Conry-Cantilena, C., Melpolder, J. C., Shih, J. W., Leuther, M., Hess, G., Gibble, J. W., Ness, P. M. & Alter, H. J. (1999). Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus. J Infect Dis 179, 1055–1061. Tanaka, E., Kiyosawa, K., Shimoda, K., Hino, K., Tacke, M., Schmolke, S., Engel, A. M. & Hess, G. (1998). Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis. J Viral Hepat 5, 153–159. 245